Which of the following monoclonal antibody is used for treatment of colorectal carcinoma?: (A) Pembrolizumab, (B) Cetuximab, (C) Rituximab, (D) Natalizumab
Answer is B. Cetuximab - Colorectal cancer, Head and neck cancer. Rituximab - B cell NHL, CLL Natalizumab - multiple sclerosis Pembrolizumab - head and neck cancer JC virus antibody titre measurement is mandatory during treatment with Natalizumab